Cardinal Health Inc. closed 2.50% below its 52-week high of $131.00, which the company reached on January 27th.
Morgan Stanley analyst Erin Wright maintained a Buy rating on Cardinal Health (CAH – Research Report) today and set a price target of $136.00.
Zacks.com on MSN13d
Cardinal Health (CAH) Increases Yet Falls Behind Market: What Investors Need to KnowCardinal Health (CAH) ended the recent trading session at $124.71, demonstrating a +0.55% swing from the preceding day's closing price. The stock's performance was behind the S&P 500's daily gain of 1 ...
Hosted on MSN14d
Why Cardinal Health (CAH) is a Top Value Stock for the Long-TermCardinal Health Inc. is a nation-wide drug distributor and provider of services to pharmacies, healthcare providers and manufacturers. The company has two reporting segments – Pharmaceutical and ...
Acting Chief Health Inspector Luke Vonotabua is visiting the Environmental Health team and delivering crucial supplies to aid in the Western Division’s recovery efforts. Vonotabua’s visit includes ...
2024 was packed with health care innovations, from a new blood test detecting Alzheimer’s disease to deep brain stimulation reversing paralysis. Heading into the New Year, medical experts are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback